SCHLAP1 and non-small cell lung carcinoma: LncRNA SChLAP1 (SWI/SNF complex antagonist associated with prostate cancer 1) is upregulated in NSCLC and promotes NSCLC cell proliferation, migration, and invasion [152], while its knockdown represses tumor growth and metastasis in vivo.